We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SN icon
1076
SharkNinja
SN
$27.2B
$280K ﹤0.01%
+3,725
New +$262K
MGY icon
1077
Magnolia Oil & Gas
MGY
$6.23B
$278K ﹤0.01%
10,990
+228
+2% +$5.82K
CRI icon
1078
Carter's
CRI
$1.24B
$278K ﹤0.01%
4,487
-967
-18% -$67.2K
FELE icon
1079
Franklin Electric
FELE
$4.44B
$277K ﹤0.01%
2,880
+71
+3% +$7.08K
BPOP icon
1080
Popular Inc
BPOP
$10.8B
$277K ﹤0.01%
3,130
+576
+23% +$50.1K
COLD icon
1081
Americold
COLD
$4.3B
$275K ﹤0.01%
10,774
-470
-4% -$11.5K
ZWS icon
1082
Zurn Elkay Water Solutions
ZWS
$7.94B
$271K ﹤0.01%
9,234
+274
+3% +$8.63K
FUL icon
1083
H.B. Fuller
FUL
$3.05B
$267K ﹤0.01%
3,467
+175
+5% +$13.6K
SEM
1084
DELISTED
Select Medical
SEM
$266K ﹤0.01%
14,081
-249
-2% -$4.25K
HBI
1085
DELISTED
Hanesbrands
HBI
$266K ﹤0.01%
53,940
-2,127
-4% -$10.4K
TWST icon
1086
Twist Bioscience
TWST
$9.1B
$265K ﹤0.01%
+5,377
New +$219K
ACIW icon
1087
ACI Worldwide
ACIW
$5.48B
$264K ﹤0.01%
6,678
+79
+1% +$2.75K
IPGP icon
1088
IPG Photonics
IPGP
$3.3B
$262K ﹤0.01%
3,109
-407
-12% -$35.2K
RNAM
1089
DELISTED
Avidity Biosciences
RNAM
$262K ﹤0.01%
+6,421
New +$184K
PTEN icon
1090
Patterson-UTI
PTEN
$4.69B
$262K ﹤0.01%
25,302
+3,851
+18% +$42.2K
CSW
1091
CSW Industrials
CSW
$5.1B
$259K ﹤0.01%
976
+35
+4% +$8.68K
AEIS icon
1092
Advanced Energy
AEIS
$11.2B
$258K ﹤0.01%
2,374
+86
+4% +$8.8K
AFRM icon
1093
Affirm
AFRM
$27.1B
$258K ﹤0.01%
8,543
-390
-4% -$12.5K
CRDO icon
1094
Credo Technology Group
CRDO
$43.6B
$257K ﹤0.01%
+8,054
New +$178K
SAP icon
1095
SAP
SAP
$255B
$257K ﹤0.01%
1,273
+219
+21% +$41.4K
ELAN icon
1096
Elanco Animal Health
ELAN
$12.1B
$257K ﹤0.01%
17,779
-52
-0.3% -$831
ACA icon
1097
Arcosa
ACA
$7.14B
$256K ﹤0.01%
3,073
+130
+4% +$10.8K
BIPC icon
1098
Brookfield Infrastructure
BIPC
$4.78B
$256K ﹤0.01%
7,614
+322
+4% +$10.7K
MC icon
1099
Moelis & Co
MC
$5.09B
$256K ﹤0.01%
4,501
+426
+10% +$23K
PECO icon
1100
Phillips Edison & Co
PECO
$5.04B
$255K ﹤0.01%
7,789
+465
+6% +$15.2K

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.